Article
Etiologic factors associated with p53 immunostaining in cutaneousmalignant melanoma.
International journal of cancer - 10 Nov 2005
Purdue Mark P, From Lynn, Kahn Harriette J, Armstrong Bruce K, Kricker Anne, Gallagher Richard P, McLaughlin John R, Klar Neil S, Marrett Loraine D
Abstract excerpt
Findings from a case-control study of cutaneous malignant melanoma (CMM) in Queensland, Australia, suggest that melanomas exhibiting p53 immunostaining possess different risk factors from those of other melanomas. To further explore this hypothesis, a case-only analysis of risk factors for p53 immunostaining with anti-p53 MAb DO-7 was undertaken in 523 people diagnosed with CMM in Canada and Australia. Phenotypic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
